发明公开
EP1257669A1 ANTISENSE MODULATION OF E2F TRANSCRIPTION FACTOR 3 EXPRESSION
审中-公开
防伪MODERIERUNG DER E2F TRANSKRIPTIONS FAKTOR 3 EXPRESSION
- 专利标题： ANTISENSE MODULATION OF E2F TRANSCRIPTION FACTOR 3 EXPRESSION
- 专利标题（中）： 防伪MODERIERUNG DER E2F TRANSKRIPTIONS FAKTOR 3 EXPRESSION
-
申请号： EP01912869.3申请日： 2001-02-21
-
公开(公告)号： EP1257669A1公开(公告)日： 2002-11-20
- 发明人: POPOFF, Ian , WYATT, Jacqueline, R.
- 申请人： ISIS PHARMACEUTICALS, INC.
- 申请人地址： 2292 Faraday Avenue Carlsbad, CA 92008 US
- 专利权人： ISIS PHARMACEUTICALS, INC.
- 当前专利权人： ISIS PHARMACEUTICALS, INC.
- 当前专利权人地址： 2292 Faraday Avenue Carlsbad, CA 92008 US
- 代理机构： Hallybone, Huw George
- 优先权： US513729 20000224
- 国际公布： WO01062973 20010830
- 主分类号： C12Q1/68
- IPC分类号： C12Q1/68 ; C07H21/04 ; A61K48/00 ; C12N15/85
摘要：
Antisense compounds, compositions and methods are provided for modulating the expression of E2F transcription factor 3. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding E2F transcription factor 3. Methods of using these compounds for modulation of E2F transcription factor 3 expression and for treatment of diseases associated with expression of E2F transcription factor 3 are provided.
信息查询
